Beijing Chunlizhengda Medical Instruments Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 25.01%

Beijing Chunlizhengda Medical Instruments Co Ltd (688236) has an Asset Resilience Ratio of 25.01% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Beijing Chunlizhengda Medical Instrument total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥885.47 Million
≈ $129.57 Million USD Cash + Short-term Investments

Total Assets

CN¥3.54 Billion
≈ $518.06 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Beijing Chunlizhengda Medical Instruments Co Ltd's Asset Resilience Ratio has changed over time. See Beijing Chunlizhengda Medical Instrument shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Beijing Chunlizhengda Medical Instruments Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Beijing Chunlizhengda Medical Instrument (688236) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥885.47 Million 25.01%
Total Liquid Assets CN¥885.47 Million 25.01%

Asset Resilience Insights

  • Very High Liquidity: Beijing Chunlizhengda Medical Instruments Co Ltd maintains exceptional liquid asset reserves at 25.01% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Beijing Chunlizhengda Medical Instruments Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Chunlizhengda Medical Instruments Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 36.63%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Shanghai Kinetic Medical Co
SHE:300326
Medical Devices 28.89%
Eurobio Scientific SA
PA:ALERS
Medical Devices 10.52%
EBR Systems Inc
AU:EBR
Medical Devices 48.75%
Aroa Biosurgery Ltd
AU:ARX
Medical Devices 12.13%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%

Annual Asset Resilience Ratio for Beijing Chunlizhengda Medical Instruments Co Ltd (2012–2024)

The table below shows the annual Asset Resilience Ratio data for Beijing Chunlizhengda Medical Instruments Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 21.52% CN¥745.80 Million
≈ $109.13 Million
CN¥3.47 Billion
≈ $507.15 Million
-1.28pp
2023-12-31 22.80% CN¥832.02 Million
≈ $121.75 Million
CN¥3.65 Billion
≈ $534.05 Million
+0.28pp
2022-12-31 22.52% CN¥767.73 Million
≈ $112.34 Million
CN¥3.41 Billion
≈ $498.96 Million
-35.37pp
2021-12-31 57.89% CN¥1.74 Billion
≈ $254.10 Million
CN¥3.00 Billion
≈ $438.94 Million
+13.08pp
2020-12-31 44.81% CN¥690.12 Million
≈ $100.99 Million
CN¥1.54 Billion
≈ $225.35 Million
+12.17pp
2012-12-31 32.64% CN¥61.21 Million
≈ $8.96 Million
CN¥187.51 Million
≈ $27.44 Million
--
pp = percentage points

About Beijing Chunlizhengda Medical Instruments Co Ltd

SHG:688236 China Medical Devices
Market Cap
$753.98 Million
CN¥5.15 Billion CNY
Market Cap Rank
#10519 Global
#3065 in China
Share Price
CN¥17.95
Change (1 day)
+3.76%
52-Week Range
CN¥15.05 - CN¥28.88
All Time High
CN¥35.53
About

Beijing Chunlizhengda Medical Instruments Co., Ltd. engages in the research and development, production, and trading of surgical implants, instruments, and related products in the People's Republic of China. The company offers implantable orthopedic medical devices, joints, dentures, spine, sports medicine, trauma and orthopedic surgical instruments. It sells its products through distributors, or… Read more